In the Media

In the Media

Kim Mulford, Courier-Post

Once a month, Carmen Caban uses a walker to make her way up the concrete steps of 511 State Street in North Camden, home of St. Luke's Catholic Medical Services.

When it rains, she navigates past a leaky ceiling near the front door. When it's freezing, she sits in a waiting room warmed by space heaters.

By Kelly Roncace, South Jersey Times

It’s a subject not many people are comfortable talking about, but it’s a conversation that needs to be initiated before it’s too late.

The discussion involves end-of-life care — the choices and decisions that need to be made when loved-ones become unable to make decisions themselves.

By Kelly Roncace, South Jersey Times

“Swallow tablets whole. Do not crush or chew.”

This warning appears on bottles of several pain killers, and for good reason.

With some drugs, if you break, crush or bite the pill, it sends an immediate high dose of medication into your system.

This is a huge concern surrounding the recent FDA approval of Zohydro — a hydrocodone-based, extended-release pain killer with little protection against breakage.

By Kim Mulford, Courier-Post

By Kim Mulford, Courier-Post

Ashley Killeen calls herself "one of the lucky ones."

WESTMONT - Jennifer Chiesa rolled her chair close to her patient, who took up a quarter of an armchair, frail and breathing heavily, with small tubes pumping oxygen into her nostrils.
"How've you been feeling?" Chiesa asked with a disarming smile.
"Good days and bad days. I like to forget about the bad," said Helen Volz, 79, a hospice patient since 2009.
Chiesa met Volz for the first time Wednesday as part of her yearlong clinical fellowship in hospice and palliative care through Samaritan Healthcare and Hospice in collaboration with Rowan University School of Osteopathic Medicine.

By South Jersey Times
With the cost of everything Jersey from turnpike hamburgers to state-owned helicopters rising, it’s good to know that undergraduate tuition at Rowan University will hold stable for the next year.

When Rowan University's new vice president for health sciences meets with potential industry partners, he starts off with a disclaimer.

Peter KeyReporter- Philadelphia Business Journal
Rowan University wants to be a 21st century research university.

If you had $100,000 to invest, would you buy Apple at $600 a share or a little-known company from Utah called Zagg at $10?


Subscribe to In the Media